Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study

BACKGROUND: Progression after high-dose melphalan with autologous stem cell transplantation (ASCT) in multiple myeloma (MM) may be due in part to immune dysfunction. Regulatory T (Treg) cells reconstitute rapidly after ASCT and inhibit immune responses against myeloma cells. METHODS: We performed a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Derman, Benjamin A, Zha, Yuanyuan, Zimmerman, Todd M, Malloy, Rebecca, Jakubowiak, Andrzej, Bishop, Michael R, Kline, Justin
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Immune Cell Therapies and Immune Cell Engineering
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057425/
https://ncbi.nlm.nih.gov/pubmed/31940591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000286
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky